SCHEMBL31497341

SCHEMBL31497341

CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)[C@@H](C)O

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CALCRL Q16602 6/20 0.52
▸ KEAP1 Q14145 4/20 0.49
▸ PRMT5 O14744 2/20 0.46
▸ WDR77 Q9BQA1 2/20 0.46
▸ STAT3 P40763 1/20 0.42
▸ RAMP1 O60894 1/20 0.42
▸ RAMP3 O60896 2/20 0.41
▸ CALCR P30988 2/20 0.41
▸ CAPN1 P07384 2/20 0.41
▸ CTSD P07339 1/20 0.41
▸ CTSE P14091 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31497325 0.95 CALCRL (0.52) CALCRLKEAP1PRMT5WDR77RAMP3
SCHEMBL31497321 0.95 KEAP1 (0.51) CALCRLKEAP1PRMT5WDR77STAT3
SCHEMBL31497348 0.93 CALCRL (0.50) CALCRLKEAP1PRMT5WDR77STAT3
SCHEMBL31497335 0.92 KEAP1 (0.55) CALCRLKEAP1PRMT5WDR77STAT3
SCHEMBL31497326 0.92 CALCRL (0.46) CALCRLKEAP1PRMT5WDR77RAMP1
SCHEMBL31497333 0.91 CALCRL (0.52) CALCRLKEAP1PRMT5WDR77RAMP3
SCHEMBL31497340 0.91 KEAP1 (0.54) CALCRLKEAP1PRMT5WDR77STAT3
SCHEMBL31497328 0.89 KEAP1 (0.52) CALCRLKEAP1PRMT5WDR77STAT3
SCHEMBL31497369 0.84 KEAP1 (0.48) CALCRLKEAP1PRMT5WDR77
SCHEMBL31126287 0.83 CALCRL (0.46) CALCRLPRMT5WDR77CAPN1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4545551-A1 PEPTIDE INHIBITOR AND USE THEREOF Chengdu Brilliant Inspiration Biotherapeutics Co., Ltd (CN) 2025-04-30 — — EP disclosed
Send feedback